Savara CFO David Lowrance Executes Complex Stock Transactions Amid Leadership Transition
Savara Inc. CFO David Lowrance executed a series of stock transactions on June 22, 2026, selling a significant portion of his holdings while simultaneously exercising options. This activity coincides with a major leadership transition and the release of clinical trial data, marking a pivotal moment for the biotech firm following a substantial year-…